NEW HOPE, Pa., June 1 /PRNewswire-FirstCall/ -- Protalex, Inc. (OTC Bulletin Board: PRTX) announced today that Steven H. Kane, President and Chief Executive Officer of Protalex, Inc. will present at the Pacific Growth Equities 2005 Life Sciences Conference at the Intercontinental Mark Hopkins Hotel in San Francisco, CA. Mr. Kane is scheduled to speak on Tuesday, June 7, 2005 at 9:30AM Pacific Time. About Protalex, Inc. Protalex is a biotechnology company engaged in the development of a new class of drug for the treatment of Rheumatoid Arthritis, Pemphigus and other autoimmune diseases. Protalex assumes no obligation to update any forward-looking statements or information set forth in its Press Releases. Protalex's actual results could differ materially from those described in Protalex's Press Releases. Factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail under the heading "Risk Factors" in Protalex's Post Effective Amendment No. 3 to the Registration Statement on Form SB-2 filed with the SEC on March 15, 2005 and other periodic reports filed with the SEC. These risks should be considered only in connection with the fully discussed risks and other factors discussed in detail in the aforementioned registration statement and Protalex, Inc.'s other periodic reports filed with the SEC.
SOURCE Protalex, Inc.